{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "4929682", "DateCompleted": {"Year": "1971", "Month": "06", "Day": "22"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "30"}, "Article": {"Language": ["ger"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0065-2997", "JournalIssue": {"Volume": "44", "PubDate": {"Year": "1971"}}, "Title": "Fortschritte der Geburtshilfe und Gynakologie", "ISOAbbreviation": "Fortschr Geburtshilfe Gynakol"}, "ArticleTitle": "[Pituitary gonadotropins. Physiology, pathology and pharmacological influence upon FSH and LH secretion in women].", "Pagination": {"StartPage": "1", "EndPage": "98", "MedlinePgn": "1-98"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Keller", "ForeName": "P J", "Initials": "PJ"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Review"], "VernacularTitle": "Hypophys\u00e4re Gonadotropine. Uber Physiologie, Pathologie und medikament\u00f6se Beeinflussung der FSH- und LH-Sekretion bei der Frau."}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Fortschr Geburtshilfe Gynakol", "NlmUniqueID": "7609286", "ISSNLinking": "0065-2997"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Androgens"}, {"RegistryNumber": "0", "NameOfSubstance": "Barbiturates"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogens"}, {"RegistryNumber": "0", "NameOfSubstance": "Hormones"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydrazines"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthalenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Progestins"}, {"RegistryNumber": "1HRS458QU2", "NameOfSubstance": "Clomiphene"}, {"RegistryNumber": "9002-67-9", "NameOfSubstance": "Luteinizing Hormone"}, {"RegistryNumber": "9002-68-0", "NameOfSubstance": "Follicle Stimulating Hormone"}, {"RegistryNumber": "U42B7VYA4P", "NameOfSubstance": "Chlorpromazine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adrenal Gland Diseases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Androgens"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Barbiturates"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chlorpromazine"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Clomiphene"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Estrogens"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism"], "DescriptorName": "Follicle Stimulating Hormone"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hormones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hydrazines"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Hyperpituitarism"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Hypopituitarism"}, {"QualifierName": ["metabolism"], "DescriptorName": "Luteinizing Hormone"}, {"QualifierName": [], "DescriptorName": "Menstruation Disturbances"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Naphthalenes"}, {"QualifierName": [], "DescriptorName": "Ovarian Diseases"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Progestins"}], "NumberOfReferences": "231"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1971", "Month": "1", "Day": "1"}, {"Year": "1971", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1971", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["4929682"]}}]}